Is there a future for metabotyping in clinical laboratories?

Bioanalysis

Volumn 7, Issue 1, 2015, Pages 5-8

  Rochat, Bertrand ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

biological passport; hospital laboratory; LC HR MS; metabolomics; metabotyping; personalized medicine; routine analysis

Indexed keywords

BIOLOGICAL MARKER;

AUTOMATION; CALIBRATION; CAPILLARY ELECTROPHORESIS; CLINICAL LABORATORY; DIAGNOSTIC PROCEDURE; ELECTROCHEMICAL ANALYSIS; FEASIBILITY STUDY; FLUORESCENCE; GAS CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HOSPITAL LABORATORY; HUMAN; HYDROPHILICITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICAL INFORMATION; METABOLITE; METABOLOMICS; METABOTYPING; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RELIABILITY; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SKILL; ULTRAVIOLET C RADIATION; LABORATORY DIAGNOSIS; PERSONALIZED MEDICINE; PROCEDURES; STANDARDS; TRENDS;

CLINICAL LABORATORY SERVICES; HUMANS; METABOLOMICS; PRECISION MEDICINE;

EID: 84920722547     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.14.268     Document Type: Review

References (13)

1. Himmelsbach M. 10 years of MS instrumental developments - impact on LC-MS/MS in clinical chemistry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 883-884, 3-17 (2012)
2. Shushan B. A review of clinical diagnostic applications of liquid chromatography-tandem mass spectrometry. Mass Spectro. Rev. 29, 930-944 (2010)
3. Highkin MK, Yates MP, Nemirovskiy OV et al. Highthroughput screening assay for sphingosine kinase inhibitors in whole blood using RapidFire mass spectrometry. J. Biomol. Screen. 16, 272-277 (2011)
4. Junot C, Fenaille F, Colsch B, Bécher F. High resolution mass spectrometry based techniques at the crossroads of metabolic pathways. Mass Spectrom. Rev. 33(6), 471-500 (2013)
5. Dénes J Szab E, Robinette SL et al. Metabonomics of newborn screening dried blood spot samples: a novel approach in the screening and diagnostics of inborn errors of metabolism. Anal. Chem. 84(22), 10113-10120 (2012)
6. Rochat B, Kottelat E, McMullen J. The future key role of LC-high-resolution-MS analyses in clinical laboratories: a focus on quantification. Bioanalysis 4, 2939-2958 (2012)
7. Liu Y, Httenhain R, Collins B, Aebersold R. Mass spectrometric protein maps for biomarker discovery and clinical research. Expert Rev. Mol. Diagn. 13, 811-825 (2013)
8. Boudah S, Olivier MF, Aros-Calt S et al. Annotation of the human serum metabolome by coupling three liquid chromatography methods to high-resolution mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 966, 34-47 (2014)
9. Yuan M, Breitkopf SB, Yang X, Asara JM. A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat. Protoc. 7, 872-881 (2012)
10. Kamlage B, Maldonado SG, Bethan B et al. Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling. Clin. Chem. 60, 399-412 (2014)
11. Croixmarie V, Umbdenstock T, Cloarec O et al. Integrated comparison of drug-related and drug-induced ultra performance liquid chromatography/mass spectrometry metabonomic profiles using human hepatocyte cultures. Anal. Chem. 81, 6061-6069 (2009)
12. Phinney KW, Ballihaut G, Bedner M et al. Development of a Standard Reference Material for metabolomics research. Anal. Chem. 85, 11732-11738 (2013)
13. Sottas PE, Vernec A. Current implementation and future of the Athlete Biological Passport. Bioanalysis 4, 1645-1652 (2012)